Please ensure Javascript is enabled for purposes of website accessibility

2018 ASCO Conference Roundup

By Shannon Jones - Updated Jun 5, 2018 at 9:37AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

All your Motley Fool coverage of the 2018 ASCO Conference in one place.

The annual American Society of Clinical Oncology Conference kicks off Friday, June 1, 2018. 

Every year, thousands of healthcare professionals, scientists, and investors assemble in Chicago to hear about the latest scientific breakthroughs redefining cancer care. Over the course of this five-day conference, hundreds of companies -- including Celgene (CELG), Gilead Sciences (GILD 0.83%), and Loxo Oncology (LOXO) -- will be providing much-anticipated pipeline updates and plenty of market-moving news. 

Not in Chicago? No worries! The Motley Fool's healthcare team has got you covered with all the latest headlines, announcements, and analysis. Be sure to check back on this page for updates!

An aerial view of Chicago's skyline.

Chicago, Illinois, home of the American Society of Clinical Oncology Conference. Image source: Getty Images.

Shannon Jones has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Bluebird Bio, Celgene, Genomic Health, and Gilead Sciences. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Celgene Corporation Stock Quote
Celgene Corporation
CELG
Nektar Therapeutics Stock Quote
Nektar Therapeutics
NKTR
$4.87 (-0.20%) $0.01
bluebird bio, Inc. Stock Quote
bluebird bio, Inc.
BLUE
$6.34 (13.42%) $0.75
Loxo Oncology Stock Quote
Loxo Oncology
LOXO
Jounce Therapeutics Stock Quote
Jounce Therapeutics
JNCE
$4.57 (9.86%) $0.41
Gilead Sciences, Inc. Stock Quote
Gilead Sciences, Inc.
GILD
$61.60 (0.83%) $0.51
Genomic Health, Inc. Stock Quote
Genomic Health, Inc.
GHDX
Immunomedics, Inc. Stock Quote
Immunomedics, Inc.
IMMU
TG Therapeutics Stock Quote
TG Therapeutics
TGTX
$7.52 (20.71%) $1.29
Blueprint Medicines Stock Quote
Blueprint Medicines
BPMC
$71.09 (4.33%) $2.95

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
377%
 
S&P 500 Returns
123%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/09/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.